Table of Contents page: Clinical Colorectal Cancer

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Select all

Download started.
Ok

Please select at least one article in order to proceed.

Treatment of Advanced BRAF-Mutated Colorectal Cancer: Where We Are and Where We Are Going

Chen Sun,
Sofia España,
Cristina Buges,
Laura Layos,
Cinta Hierro,
Jose Luis Manzano

Published online: February 03, 2022

p71-79

Lateral Lymph Nodes in Rectal Cancer: Do we all Think the Same? A Review of Multidisciplinary Obstacles and Treatment Recommendations

Tania C. Sluckin,
Alice M. Couwenberg,
Doenja M.J. Lambregts,
...
Pieter J. Tanis,
Corrie A.M. Marijnen,
Miranda Kusters

Published online: February 19, 2022

p80-88

Open Access

The Future of ctDNA-Defined Minimal Residual Disease: Personalizing Adjuvant Therapy in Colorectal Cancer

Alisha Bent,
Shreya Raghavan,
Arvind Dasari,
Scott Kopetz

Published online: March 26, 2022

p89-95

Tumor Regression Grade as a Prognostic Factor in Metastatic Colon Cancer Following Preoperative Chemotherapy

Yufei Yang,
Dakui Luo,
Ruoxin Zhang,
Sanjun Cai,
Qingguo Li,
Xinxiang Li

Published online: November 14, 2021

p96-106

Impact of Tumor Location on Patient Outcomes in Small Bowel Cancers

Irene S. Yu,
Zamzam Al-Hashami,
Parv Chapani,
...
Sharlene Gill,
Heather C. Stuart,
Jonathan M. Loree

Published online: November 30, 2021

p107-113

Immediate Adjuvant Chemotherapy in Non-Metastatic Colon Cancer: Phase I Trial Evaluating a Novel Treatment Protocol

Mehraneh D. Jafari,
Joseph C. Carmichael,
Farshid Dayyani,
...
Lari Wenzel,
Jason A. Zell,
Alessio Pigazzi

Published online: November 28, 2021

p114-121

Assessment of Metastatic Colorectal Cancer Patients’ Preferences for Biologic Treatments in Germany Using a Discrete Choice Experiment

Volker Heinemann,
Moushmi Singh,
Fränce Hardtstock,
...
Andrea Lebioda,
Tanja Schaller-Kranz,
Robert Bartsch

Published online: December 20, 2021

p122-131

$Sequential Treatment With Trifluridine/Tipiracil and Regorafenib in Refractory Metastatic Colorectal Cancer Patients: An AGEO Prospective “Real-World Study”$

Sequential Treatment With Trifluridine/Tipiracil and Regorafenib in Refractory Metastatic Colorectal Cancer Patients: An AGEO Prospective “Real-World Study”

Clélia Coutzac,
Isabelle Trouilloud,
Pascal Artru,
...
Christelle De La Fouchardière,
David Tougeron,
Julien Taieb

Published online: February 14, 2022

p132-140

Final results of the CAVE trial in RAS wild type metastatic colorectal cancer patients treated with cetuximab plus avelumab as rechallenge therapy: Neutrophil to lymphocyte ratio predicts survival

Davide Ciardiello,
Vincenzo Famiglietti,
Stefania Napolitano,
...
Erika Martinelli,
Fortunato Ciardiello,
Giulia Martini

Published online: January 16, 2022

p141-148

Simplified Graded Infusion Strategy for Mitigation of Oxaliplatin Hypersensitivity

Salvador Alonso Martinez,
Neil H. Segal,
Andrea Cercek,
...
Armin Shahrokni,
Louise Connell,
Leonard B. Saltz

Published online: January 18, 2022

p149-153

Quality of Life and Survival of Metastatic Colorectal Cancer Patients Treated With Trifluridine-Tipiracil (QUALITAS)

Patricia A.H. Hamers,
Geraldine R. Vink,
Marloes A.G. Elferink,
...
Miriam Koopman,
Anne M. May
on behalf of the QUALITAS study group

Published online: March 24, 2022

p154-166

Open Access

Leptomeningeal Metastases From Colorectal Signet-Ring Cell Cancer: A Case Report and Literature Review

Bernard J. Smilde,
Anne F. Louwerenburg,
Marije M. van Santen,
Mathijs P. Hendriks

Published online: November 28, 2021

p167-169

The CIRCULATE Trial: Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation (AIO-KRK-0217)

Gunnar Folprecht,
Anke Reinacher-Schick,
Jürgen Weitz,
...
Michael Kramer,
Christian Thiede,
Andrea Tannapfel

Published online: September 14, 2021

p170-174

Editorial Board

Published in issue: June 2022

A3-A6

June 2022

Reviews

Treatment of Advanced BRAF-Mutated Colorectal Cancer: Where We Are and Where We Are Going

Lateral Lymph Nodes in Rectal Cancer: Do we all Think the Same? A Review of Multidisciplinary Obstacles and Treatment Recommendations

The Future of ctDNA-Defined Minimal Residual Disease: Personalizing Adjuvant Therapy in Colorectal Cancer

Original Studies

Tumor Regression Grade as a Prognostic Factor in Metastatic Colon Cancer Following Preoperative Chemotherapy

Impact of Tumor Location on Patient Outcomes in Small Bowel Cancers

Immediate Adjuvant Chemotherapy in Non-Metastatic Colon Cancer: Phase I Trial Evaluating a Novel Treatment Protocol

Assessment of Metastatic Colorectal Cancer Patients’ Preferences for Biologic Treatments in Germany Using a Discrete Choice Experiment

Sequential Treatment With Trifluridine/Tipiracil and Regorafenib in Refractory Metastatic Colorectal Cancer Patients: An AGEO Prospective “Real-World Study”

Final results of the CAVE trial in RAS wild type metastatic colorectal cancer patients treated with cetuximab plus avelumab as rechallenge therapy: Neutrophil to lymphocyte ratio predicts survival

Simplified Graded Infusion Strategy for Mitigation of Oxaliplatin Hypersensitivity

Quality of Life and Survival of Metastatic Colorectal Cancer Patients Treated With Trifluridine-Tipiracil (QUALITAS)

Case Report

Leptomeningeal Metastases From Colorectal Signet-Ring Cell Cancer: A Case Report and Literature Review

Current Trial Report

The CIRCULATE Trial: Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation (AIO-KRK-0217)

Available Exclusively Online at www.clinical-colorectal-cancer.com

Evaluation of Clinical and Pathological Factors to Predict High Risk of Recurrence in Patients With Stage II Colon Cancer

Health-Related Quality of Life Analysis in Metastatic Colorectal Cancer Patients Treated by Second-Line Chemotherapy, Associated With Either Cetuximab or Bevacizumab: The PRODIGE 18 Randomized Phase II Study

Impact of Relative Dose Intensity of FOLFOX Adjuvant Chemotherapy on Risk of Death Among Stage III Colon Cancer Patients

Does Physical Activity Play a Role in the Efficacy of RegoNivo for MSS-mCRC?

Metastasis-Directed Radiotherapy for Oligoprogressive or Oligopersistent Metastatic Colorectal Cancer

The Role of Intestinal Microbiota in Metastatic Colorectal Cancer Patients Treated With Capecitabine

Defibrotide for Sinusoidal Obstruction Syndrome and Nodular Regenerative Hyperplasia After Oxaliplatin-Based Hepatic Intra-Arterial Chemotherapy: A Case Report

Long-term Patterns of Failure and the Value of Blood Prognostic Markers in Anal Cancers Treated With Intensity-Modulated Radiation Therapy

Colorectal Cancer Screening in the Elderly: Is Age Just a Number?

Modification to Systemic Anticancer Therapy at the Start of the COVID-19 Pandemic and its Overall Impact on Survival Outcomes in Patients with Colorectal Cancer

Targeting Hyaluronic Acid and Peritoneal Dissemination in Colorectal Cancer

Early-Onset Colorectal Cancer in Patients under 50 Years of Age: Demographics, Disease Characteristics, and Survival

Trifluridine/Tipiracil in Combination with Bevacizumab in First-Line for Metastatic Colorectal Cancer: A Way Forward. A Point of View Based on Cost-Effectiveness

Frontmatter

Editorial Board

Table of contents